| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 22 |
| 1 | OLANZAPINE PAMOATE | 17 |
| 2 | ASPIRIN | 14 |
| 3 | ASPIRIN 325 MG | 14 |
| 4 | ASPIRIN 81 MG | 14 |
| 5 | DICLOFENAC | 14 |
| 6 | DICLOFENAC SODIUM | 14 |
| 7 | ACETAMINOPHEN | 13 |
| 8 | ACETAMINOPHEN 500MG | 13 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHROMIC CHLORIDE | 11 | 0.0128 |
| 1 | HYALURONATE SODIUM | 12 | 0.0078 |
| 2 | POTASSIUM IODIDE | 11 | 0.0074 |
| 3 | EFINACONAZOLE | 13 | 0.0066 |
| 4 | CODEINE SULFATE | 13 | 0.0039 |
| 5 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 5 | 0.0026 |
| 6 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | 5 | 0.0026 |
| 7 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 11 | 0.0018 |
| 8 | MAGNESIUM CITRATE ORAL SOLUTION | 11 | 0.0018 |
| 9 | MAGNESIUM CITRATE | 11 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 23 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 3 | Azole Antifungal [EPC] | 13 |
| 4 | GLP-2 Analog [EPC] | 13 |
| 5 | Loop Diuretic [EPC] | 12 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 7 | Calcium [EPC] | 7 |
| 8 | Provitamin D2 Compound [EPC] | 6 |
| 9 | Expectorant [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 13 | 0.0010 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 3 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Azole Antifungal [EPC] | 13 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Atypical Antipsychotic [EPC] | 23 | 0.0001 |
| 8 | Calcium [EPC] | 7 | 0.0000 |
| 9 | Progesterone [EPC] | 1 | 0.0000 |